NEU 6.41% $15.27 neuren pharmaceuticals limited

Share Price, page-3685

  1. 5,960 Posts.
    lightbulb Created with Sketch. 18456
    Please show me that Acadia have spent $300 million.

    Please show me that Acadia have the current ability to distribute in the EU, AUS, Japan, China.


    I agree and have stated numerous times that Acadia doesn’t currently have the ability to distribute outside of the US. And it’s not only the international distribution capacity that Acadia lacks, but also intimate knowledge of the complex regulatory requirements of the various jurisdictions.

    From your first statement, it appears that you are casting doubt on Little T’s assertion that Acadia has already spent A$300m on trofinetide.

    It’s easily checked by referring to Acadia’s annual filings but I’ll do the work for you.

    Acadia reported external service providers for trofinetide to have cost the following (in USD).

    2018 12,083,000
    2019 27,974,000
    2020 47,614,000
    2021 39,814,000
    2022 (Q 1,2,3) 46,944,000
    2022 (Q4-est.) 15,000,000
    Lic. Upfront 10,000,000
    Milestone 1 10,000,000

    TOTAL US$209,402,000
    A$303,206,770

    The above amount doesn’t include Acadia’s internal costs for trofinetide, nor does it include any spending on trofinetide in 2023.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.